Hana Algül

17.8k total citations · 3 hit papers
134 papers, 6.5k citations indexed

About

Hana Algül is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Hana Algül has authored 134 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 53 papers in Surgery and 34 papers in Cancer Research. Recurrent topics in Hana Algül's work include Pancreatic and Hepatic Oncology Research (59 papers), Pancreatitis Pathology and Treatment (39 papers) and Cancer Genomics and Diagnostics (20 papers). Hana Algül is often cited by papers focused on Pancreatic and Hepatic Oncology Research (59 papers), Pancreatitis Pathology and Treatment (39 papers) and Cancer Genomics and Diagnostics (20 papers). Hana Algül collaborates with scholars based in Germany, United States and United Kingdom. Hana Algül's co-authors include Marina Lesina, Roland M. Schmid, Matthias Treiber, Sonja M. Wörmann, Albrecht Neeße, David A. Tuveson, Thomas M. Gress, Michele Reni, Anke Reinacher‐Schick and Daniel Hochhauser and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hana Algül

122 papers receiving 6.5k citations

Hit Papers

Maintenance Olaparib for Germline BRCA ... 2011 2026 2016 2021 2019 2011 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
    2019 1.5k citations Talia Golan, Pascal Hammel et al. New England Journal of Medicine profile →
  2. Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
    2011 671 citations Marina Lesina, Matthias Treiber et al. profile →
  3. Stromal biology and therapy in pancreatic cancer: a changing paradigm
    2015 419 citations Albrecht Neeße, Hana Algül et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hana Algül Germany 38 4.0k 1.9k 1.8k 1.5k 1.3k 134 6.5k
Markus Guba Germany 38 3.8k 0.9× 3.0k 1.6× 2.0k 1.1× 1.3k 0.8× 794 0.6× 194 8.5k
Joji Kitayama Japan 49 2.7k 0.7× 2.9k 1.6× 1.5k 0.8× 1.4k 0.9× 857 0.6× 195 7.4k
Tetsuo Ohta Japan 46 3.7k 0.9× 1.9k 1.0× 3.0k 1.7× 1.1k 0.7× 628 0.5× 338 7.3k
Christoph Michalski Germany 44 4.9k 1.2× 1.8k 1.0× 2.6k 1.4× 1.6k 1.0× 625 0.5× 175 7.4k
Bo Hu China 38 2.5k 0.6× 2.9k 1.6× 836 0.5× 1.7k 1.1× 1.5k 1.1× 118 6.7k
Peter A. van Dam Belgium 49 3.6k 0.9× 2.8k 1.5× 737 0.4× 2.5k 1.6× 891 0.7× 186 7.2k
Shuang–Jian Qiu China 48 3.6k 0.9× 2.7k 1.5× 1.8k 1.0× 2.0k 1.3× 990 0.7× 174 8.6k
Kwok Wah Chan Hong Kong 46 2.5k 0.6× 3.2k 1.7× 1.1k 0.6× 1.7k 1.1× 1.1k 0.8× 162 8.0k
Sylvain Ladoire France 40 4.3k 1.1× 1.4k 0.8× 866 0.5× 884 0.6× 3.3k 2.5× 186 7.5k
Muh‐Hwa Yang Taiwan 48 2.9k 0.7× 4.0k 2.2× 852 0.5× 2.2k 1.4× 837 0.6× 164 7.6k

Countries citing papers authored by Hana Algül

Since Specialization
Citations

This map shows the geographic impact of Hana Algül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Algül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Algül more than expected).

Fields of papers citing papers by Hana Algül

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Algül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Algül. The network helps show where Hana Algül may publish in the future.

Co-authorship network of co-authors of Hana Algül

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Algül. A scholar is included among the top collaborators of Hana Algül based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Algül. Hana Algül is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lesina, Marina, Qinghua Wang, Alexandra Berninger, et al.. (2024). DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue. Angewandte Chemie International Edition. 63(26). e202318485–e202318485. 8 indexed citations
3.
Kindler, Hedy L., Pascal Hammel, Michele Reni, et al.. (2022). Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Journal of Clinical Oncology. 40(34). 3929–3939. 120 indexed citations
4.
Cridge, Harry, Sue Yee Lim, Hana Algül, & Jörg M. Steiner. (2022). New insights into the etiology, risk factors, and pathogenesis of pancreatitis in dogs: Potential impacts on clinical practice. Journal of Veterinary Internal Medicine. 36(3). 847–864. 22 indexed citations
5.
Lange, Sebastian, H. Carlo Maurer, Kenneth P. Olive, et al.. (2021). PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer. JCI Insight. 6(8). 7 indexed citations
6.
Algül, Hana, Marina Lesina, Andreas Blutke, et al.. (2020). Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice. Molecular Oncology. 14(8). 1653–1669. 7 indexed citations
7.
8.
Golan, Talia, Pascal Hammel, Michele Reni, et al.. (2019). Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer. New England Journal of Medicine. 381(4). 317–327. 1468 indexed citations breakdown →
9.
Hammel, P., Hedy L. Kindler, Michele Reni, et al.. (2019). Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Annals of Oncology. 30(12). 1959–1968. 33 indexed citations
10.
Gukovskaya, Anna S., Ilya Gukovsky, Hana Algül, & Aida Habtezion. (2017). Autophagy, Inflammation, and Immune Dysfunction in the Pathogenesis of Pancreatitis. Gastroenterology. 153(5). 1212–1226. 257 indexed citations
11.
Monte, Lucia De, Sonja M. Wörmann, Emanuela Brunetto, et al.. (2016). Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. Cancer Research. 76(7). 1792–1803. 124 indexed citations
12.
Phillip, Veit, Sebastian Rasch, Oliver Ebert, et al.. (2016). Influence of Sorafenib and Bevacizumab on pancreatic volume – A monocentric CT based analysis. Pancreatology. 16(4). 621–624. 8 indexed citations
13.
Neeße, Albrecht, Hana Algül, David A. Tuveson, & Thomas M. Gress. (2015). Stromal biology and therapy in pancreatic cancer: a changing paradigm. Gut. 64(9). 1476–1484. 419 indexed citations breakdown →
14.
Schneider, Jochen, Andreas Obermeier, Susanne Feihl, et al.. (2015). Microbial Colonization of Pancreatic Duct Stents. Pancreas. 44(5). 786–790. 13 indexed citations
15.
Saito, Taku, Makoto Hirata, Toshiyuki Ikeda, et al.. (2012). GSK-3α and GSK-3β Proteins Are Involved in Early Stages of Chondrocyte Differentiation with Functional Redundancy through RelA Protein Phosphorylation. Journal of Biological Chemistry. 287(35). 29227–29236. 44 indexed citations
16.
Eser, Stefan, Marlena Messer, Philipp Eser, et al.. (2011). In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. Proceedings of the National Academy of Sciences. 108(24). 9945–9950. 67 indexed citations
17.
Treiber, Matthias, Patrick Neuhöfer, Henrik Einwächter, et al.. (2011). Myeloid, but Not Pancreatic, RelA/p65 Is Required for Fibrosis in a Mouse Model of Chronic Pancreatitis. Gastroenterology. 141(4). 1473–1485.e7. 62 indexed citations
18.
Pittet, Lynnelle A., Lee J. Quinton, Kazuko Yamamoto, et al.. (2011). Earliest Innate Immune Responses Require Macrophage RelA during Pneumococcal Pneumonia. American Journal of Respiratory Cell and Molecular Biology. 45(3). 573–581. 41 indexed citations
19.
Algül, Hana & Roland M. Schmid. (2008). Pancreatic cancer: a plea for good and comprehensive morphological studies. European Journal of Gastroenterology & Hepatology. 20(8). 713–715. 6 indexed citations
20.
Geisler, Fabian, Hana Algül, Marc Riemann, & Roland M. Schmid. (2005). Questioning Current Concepts in Acute Pancreatitis: Endotoxin Contamination of Porcine Pancreatic Elastase Is Responsible for Experimental Pancreatitis-Associated Distant Organ Failure. The Journal of Immunology. 174(10). 6431–6439. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Guba Breakdown of academic impact, for papers by Joji Kitayama Breakdown of academic impact, for papers by Tetsuo Ohta Breakdown of academic impact, for papers by Christoph Michalski Breakdown of academic impact, for papers by Bo Hu Breakdown of academic impact, for papers by Peter A. van Dam Breakdown of academic impact, for papers by Shuang–Jian Qiu Breakdown of academic impact, for papers by Kwok Wah Chan Breakdown of academic impact, for papers by Sylvain Ladoire Breakdown of academic impact, for papers by Muh‐Hwa Yang
Rankless by CCL
2026